Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lipton

Showing results (21-30 of 832) with videos related to

Pageof 84
Sort By:
Archives of Neurology|November 1, 1989
Growth factors for neuronal survival and process regeneration. Implications in the mammalian central nervous systemS A Lipton
Current Opinion in Pharmacology|July 23, 2022
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathwaysStuart A Lipton
Free Radical Biology & Medicine|October 15, 2022
Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's diseaseStuart A Lipton
The European Journal of Neuroscience|January 1, 1992
7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal CulturesStuart A. Lipton
Current Alzheimer Research|June 25, 2005
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonismStuart A Lipton
The American Journal of Psychiatry|October 1, 1988
Accuracy of diagnosis in public hospitalsA A Lipton
Brain Research|August 26, 1985
Conditioning hyperpolarization reveals a property of the light-sensitive current in photoreceptors that is modified by cGMP and EGTAS A Lipton
Annals of Neurology|February 1, 1993
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicityS A Lipton
The Journal of Prosthetic Dentistry|June 1, 1996
The Dentist Scientist Award program and prosthodonticsJ A Lipton
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disordersStuart A Lipton
Pageof 84

Showing results (21-30 of 832) with videos related to

Sort By:
Pageof 84
Archives of Neurology|November 1, 1989
Growth factors for neuronal survival and process regeneration. Implications in the mammalian central nervous systemS A Lipton
Current Opinion in Pharmacology|July 23, 2022
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathwaysStuart A Lipton
Free Radical Biology & Medicine|October 15, 2022
Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's diseaseStuart A Lipton
The European Journal of Neuroscience|January 1, 1992
7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal CulturesStuart A. Lipton
Current Alzheimer Research|June 25, 2005
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonismStuart A Lipton
The American Journal of Psychiatry|October 1, 1988
Accuracy of diagnosis in public hospitalsA A Lipton
Brain Research|August 26, 1985
Conditioning hyperpolarization reveals a property of the light-sensitive current in photoreceptors that is modified by cGMP and EGTAS A Lipton
Annals of Neurology|February 1, 1993
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicityS A Lipton
The Journal of Prosthetic Dentistry|June 1, 1996
The Dentist Scientist Award program and prosthodonticsJ A Lipton
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disordersStuart A Lipton
Pageof 84